z-logo
Premium
Neonatal hyperekplexia with homozygous p.R392H mutation in GLRA1
Author(s) -
Hmami Fouzia,
Wood SianElin,
Chaouki Sana,
Oulmaati Abdellah,
Hida Mustapha,
Rees Mark I.,
Chung SeoKyung,
Bouharrou Abdelhak
Publication year - 2014
Publication title -
epileptic disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.673
H-Index - 53
eISSN - 1950-6945
pISSN - 1294-9361
DOI - 10.1684/epd.2014.0663
Subject(s) - clonazepam , hypertonia , medicine , neonatal intensive care unit , asphyxia , pediatrics , amino acid substitution , tonic (physiology) , anesthesia , mutation , biology , genetics , gene
Hyperekplexia is a rare neurogenetic disorder, frequently misdiagnosed in neonates with a risk of apnoea, asphyxia, and sudden infant death. We present video sequences of a male newborn, admitted on the second day of life to the neonatal intensive care unit, due to tonic‐clonic movements. Following clinical and paraclinical investigations, a final diagnosis of hyperekplexia was made. Genetic analysis revealed a homozygous mutation in GLRA1 resulting in a R392H amino acid substitution and altered receptor dynamics, as indicated from previous work. The infant showed a marked improvement of the startle response and muscle hypertonia with clonazepam which is a strong clinical feature of GLRA1 ‐mediated hyperekplexia. [ Published with video sequences ]

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom